Latest Resources

9 December 2020

Neo-colonial economies and ecologies, smallholder farmers and multiple shocks: The case of cyclon...

We are pleased to share with you the second discussion paper in our “Multiple Shocks in Africa Series”, Neo-colonial economies and ecologies, smallholder farmers and multiple shocks: The case of cyclones Idai and Kenneth in Mozambique and Zimbabwe. (Por favor clique aqui para Português). The paper exposes how the two cyclones that battered Mozambique and […]

18 July 2017

GM Cotton push in Swaziland: Next target for failed Bt cotton

This paper examines the application of the Bt cotton field trials currently underway in Swaziland. This is situated within the broader wave of GM application and trials across the continent, along with the weakening of national biosafety regulations, as part of the GM push across Africa. This paper is based on research on the Swaziland […]

9 March 2011

How US sorghum seed distributions undermine the FAO Plant Treaty’s Multilateral System

New data from ICRISAT and the US Department of Agriculture and a comparison of genebank records indicates that half of more of ICRISAT’s sorghum genebank collection is also being distributed outside of the Multilateral System. This yawning gap creates an economic incentive for the Multilateral System and its benefit-sharing requirements to be avoided. USDA’s sorghum […]

19 February 2011

Agrochemical giant DuPont to sell Bolivian sorghum gene

In 2012 multinational giant DuPont plans to begin selling sorghum varieties containing a valuable gene taken from a sudan grass that was collected in 2006 in Bolivia. The gene, branded as ‘Inzen A II’, makes sorghum plants tolerant to herbicides made by DuPont and other companies, and was acquired under exclusive license from Kansas State […]

4 March 2010

The GM stacked gene revolution: A biosafety nightmare

Stacked GMOs are those containing more than one gene genetically engineered into a crop plant. A controversial stacked GMO, Smarstax containing 8 such genetically engineered genes, was commercially approved in the US, Canada, Japan and South Korea during 2009. Stacked gene varieties are highly complex, posing new biosafety risks that outpace the capacity of regulatory […]